Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Company Info
ISIN | VGG111961055 |
---|---|
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | $3.34B |
---|---|
EPS (TTM) | -$6.90 |
Gross Profit (TTM) | -$2.75M |
EBITDA (TTM) | -$445.61M |
Year Range | $16.45 - $62.21 |
Target Price | $58.25 |
Short % | 12.76% |
Short Ratio | 6.07 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BHVN vs. SPY, BHVN vs. CRWD
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Biohaven Pharmaceutical Holding Company Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Biohaven Pharmaceutical Holding Company Ltd. had a return of -5.98% year-to-date (YTD) and 69.08% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -5.98% | 13.20% |
1 month | 14.97% | -1.28% |
6 months | -10.52% | 10.32% |
1 year | 69.08% | 18.23% |
5 years (annualized) | N/A | 12.31% |
10 years (annualized) | N/A | 10.58% |
Monthly Returns
The table below presents the monthly returns of BHVN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 3.93% | 8.23% | 13.61% | -29.05% | -9.54% | -1.11% | -5.98% | ||||||
2023 | 37.54% | -19.96% | -10.60% | -4.25% | 33.87% | 36.61% | -16.89% | -8.00% | 42.21% | 1.92% | 25.69% | 28.45% | 208.36% |
2022 | -13.70% | 163.02% | -4.53% | -12.26% | 90.14% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of BHVN is 80, placing it in the top 20% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Biohaven Pharmaceutical Holding Company Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Biohaven Pharmaceutical Holding Company Ltd. was 45.15%, occurring on Jun 18, 2024. The portfolio has not yet recovered.
The current Biohaven Pharmaceutical Holding Company Ltd. drawdown is 32.65%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-45.15% | Mar 14, 2024 | 67 | Jun 18, 2024 | — | — | — |
-35.9% | Jul 18, 2023 | 48 | Sep 22, 2023 | 13 | Oct 11, 2023 | 61 |
-34.17% | Jan 24, 2023 | 53 | Apr 10, 2023 | 37 | Jun 1, 2023 | 90 |
-25.44% | Sep 27, 2022 | 4 | Sep 30, 2022 | 3 | Oct 5, 2022 | 7 |
-24.76% | Nov 2, 2022 | 38 | Dec 27, 2022 | 10 | Jan 11, 2023 | 48 |
Volatility
Volatility Chart
The current Biohaven Pharmaceutical Holding Company Ltd. volatility is 11.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
P/E Ratio
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Biohaven Pharmaceutical Holding Company Ltd..
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |